SENS stock should follow a similar trajectory to DexCom, and if it does, it will likely explode in price following FDA approval.
The post FDA Approval for Senseonics’ Glucose Monitor Could Double the Stock Price appeared first on InvestorPlace.
FDA Approval For Senseonics’ Glucose Monitor Could Double The Stock Price
- by Mark R. Hake
